Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Receivables: 2014-2021

Historic Receivables for Agios Pharmaceuticals (AGIO) over the last 7 years, with Dec 2021 value amounting to $4.4 million.

  • Agios Pharmaceuticals' Receivables was N/A to $4.4 million in Q4 2021 from the same period last year, while for Dec 2021 it was $54.7 million, marking a year-over-year change of. This contributed to the annual value of $4.4 million for FY2021, which is N/A change from last year.
  • According to the latest figures from FY2021, Agios Pharmaceuticals' Receivables is $4.4 million, which was down 58.27% from $10.5 million recorded in FY2019.
  • In the past 5 years, Agios Pharmaceuticals' Receivables ranged from a high of $10.5 million in FY2019 and a low of $2.4 million during FY2017.
  • Moreover, its 2-year median value for Receivables was $7.4 million (2019), whereas its average is $7.4 million.
  • In the last 5 years, Agios Pharmaceuticals' Receivables slumped by 74.95% in 2017 and then soared by 207.92% in 2018.
  • Agios Pharmaceuticals' Receivables (Yearly) stood at $2.4 million in 2017, then soared by 207.92% to $7.5 million in 2018, then surged by 39.17% to $10.5 million in 2019, then reached $4.4 million in 2021.